SCHEMBL18101033

SCHEMBL18101033

CCCC(C)(C)C(=O)OCCOC(=O)c1ccc(C(=O)O)c(C(=O)O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.44
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
LMNA P02545 3/20 0.40
POLB P06746 2/20 0.39
KDM4E B2RXH2 2/20 0.39
ESR1 P03372 4/20 0.39
ALDH1A1 P00352 4/20 0.39
TSHR P16473 4/20 0.39
TDP1 Q9NUW8 2/20 0.39
CHRM1 P11229 1/20 0.39
SLC6A2 P23975 1/20 0.39
KDR P35968 1/20 0.39
MAPK1 P28482 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 2/20 0.38
PPARA Q07869 1/20 0.38
GPR35 Q9HC97 1/20 0.38
CYP2D6 P10635 1/20 0.38
NR1H2 P55055 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18101013 0.90 MEN1 (0.40) MEN1KMT2ALMNAPOLBKDM4E
SCHEMBL12311685 0.82 LMNA (0.59) MEN1KMT2ALMNAPOLBKDM4E
SCHEMBL1263397 0.82 CDC25A (0.52) MEN1KMT2ALMNAPOLBKDM4E
SCHEMBL30306346 0.82 CDC25A (0.52) MEN1KMT2ALMNAPOLBKDM4E
SCHEMBL1104237 0.81 TSHR (0.39) MEN1KMT2ALMNAKDM4EALDH1A1
SCHEMBL1104031 0.81 KDM4E (0.40) MEN1KMT2ALMNAKDM4EALDH1A1
SCHEMBL4138134 0.79 MEN1 (0.60) MEN1KMT2ALMNAKDM4EESR1
SCHEMBL18099386 0.79 CDC25A (0.36) MEN1KMT2ALMNAPOLBKDM4E
SCHEMBL12311661 0.78 CDC25A (0.45) MEN1KMT2ALMNAPOLBKDM4E
SCHEMBL27557411 0.78 ALDH1A1 (0.59) MEN1KMT2ALMNAPOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160279251-A1 RANDOM COPOLYMER THERAPEUTIC AGENT CARRIERS AND ASSEMBLIES THEREOF UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) 2016-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160279251-A1 RANDOM COPOLYMER THERAPEUTIC AGENT CARRIERS AND ASSEMBLIES THEREOF POLI, POLM, POLA1 ELANE 646/4885MEN1 3760/4885KMT2A 4209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.